mapk pathway involvement Search Results


90
SuperArray Bioscience Corporation gearray gene expression array systems
Gearray Gene Expression Array Systems, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gearray gene expression array systems/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
gearray gene expression array systems - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Matos labs receptor tyrosine kinase/mitogen-activated protein (map) kinase pathway
Receptor Tyrosine Kinase/Mitogen Activated Protein (Map) Kinase Pathway, supplied by Matos labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/receptor tyrosine kinase/mitogen-activated protein (map) kinase pathway/product/Matos labs
Average 90 stars, based on 1 article reviews
receptor tyrosine kinase/mitogen-activated protein (map) kinase pathway - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc signaling pathways
Signaling Pathways, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/signaling pathways/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
signaling pathways - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

90
Basler c-jun n-terminal kinase (jnk) pathway
C Jun N Terminal Kinase (Jnk) Pathway, supplied by Basler, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c-jun n-terminal kinase (jnk) pathway/product/Basler
Average 90 stars, based on 1 article reviews
c-jun n-terminal kinase (jnk) pathway - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Millar Inc mapk signaling pathway
Mapk Signaling Pathway, supplied by Millar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mapk signaling pathway/product/Millar Inc
Average 90 stars, based on 1 article reviews
mapk signaling pathway - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc mapk pathway involvement
ESK inhibits <t>MAPK</t> pathway activation in the SDH of BCP rats. ( A–D ) Representative WB images and quantification of <t>phosphorylated</t> <t>JNK</t> ( B ), p38 ( C ), and ERK ( D ) levels. Data are mean ± SEM of biological replicates n = 3. *** P < 0.001 versus sham plus vehicle group, # P < 0.05, ## P < 0.01, ### P < 0.001 versus BCP plus vehicle group, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test. ( E ) Schematic of experimental timeline showing repeated intrathecal administration of ESK, SB203580 (p38 inhibitor), or SP600125 (JNK inhibitor) on POD 13 to 16. ( F ) Co-treatment with ESK enhanced the MAPK inhibitors induced increase in PWT after intrathecal administration. Notably, co-administration of MAPK inhibitors did not further enhance ESK’s analgesic effect, suggesting that its antinociceptive action mainly involves MAPK pathway inhibition. Data are mean ± SEM of biological replicates n = 7–8 rats/group. Two-way ANOVA with repeated measures followed by post hoc Tukey test. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. BCP + DMSO; # P < 0.05, BCP + ESK+SB203580 vs. BCP + SB203580, BCP + ESK+SP600125 vs. BCP + SP600125 at corresponding time points. ( G ) Western blot of IL-1β, IL-6, and TNF-α expression in the SDH. ( H–J ) Quantification of cytokine levels showed further reductions in IL-1β ( H ), IL-6 ( I ), and TNF-α ( J ) with combined ESK and MAPK inhibitor treatment. Data are mean ± SEM of biological replicates n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test.
Mapk Pathway Involvement, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mapk pathway involvement/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
mapk pathway involvement - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
Tsang MD Inc and dawid, 2004
ESK inhibits <t>MAPK</t> pathway activation in the SDH of BCP rats. ( A–D ) Representative WB images and quantification of <t>phosphorylated</t> <t>JNK</t> ( B ), p38 ( C ), and ERK ( D ) levels. Data are mean ± SEM of biological replicates n = 3. *** P < 0.001 versus sham plus vehicle group, # P < 0.05, ## P < 0.01, ### P < 0.001 versus BCP plus vehicle group, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test. ( E ) Schematic of experimental timeline showing repeated intrathecal administration of ESK, SB203580 (p38 inhibitor), or SP600125 (JNK inhibitor) on POD 13 to 16. ( F ) Co-treatment with ESK enhanced the MAPK inhibitors induced increase in PWT after intrathecal administration. Notably, co-administration of MAPK inhibitors did not further enhance ESK’s analgesic effect, suggesting that its antinociceptive action mainly involves MAPK pathway inhibition. Data are mean ± SEM of biological replicates n = 7–8 rats/group. Two-way ANOVA with repeated measures followed by post hoc Tukey test. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. BCP + DMSO; # P < 0.05, BCP + ESK+SB203580 vs. BCP + SB203580, BCP + ESK+SP600125 vs. BCP + SP600125 at corresponding time points. ( G ) Western blot of IL-1β, IL-6, and TNF-α expression in the SDH. ( H–J ) Quantification of cytokine levels showed further reductions in IL-1β ( H ), IL-6 ( I ), and TNF-α ( J ) with combined ESK and MAPK inhibitor treatment. Data are mean ± SEM of biological replicates n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test.
And Dawid, 2004, supplied by Tsang MD Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/and dawid, 2004/product/Tsang MD Inc
Average 90 stars, based on 1 article reviews
and dawid, 2004 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GeneGo Inc canonical pathway maps
Comparison of gene expression and <t>GeneGo</t> <t>canonical</t> <t>pathway</t> <t>maps</t> among T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells . A. Parameters for comparison are set at threshold of 3 with p-value of 0.05. The common genes are indicated by blue/white strips. The white area denotes similar genes in which three of four are the same. The unique genes are marked as color bands: 1) T3/HDF, orange; 2) T3/CMHDF, blue; 3) T5/MEF, red; 4) T3/CMMEF, green. B. The top 10 GeneGo canonical pathway maps.
Canonical Pathway Maps, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/canonical pathway maps/product/GeneGo Inc
Average 90 stars, based on 1 article reviews
canonical pathway maps - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioCarta tgf-beta signalling
Comparison of gene expression and <t>GeneGo</t> <t>canonical</t> <t>pathway</t> <t>maps</t> among T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells . A. Parameters for comparison are set at threshold of 3 with p-value of 0.05. The common genes are indicated by blue/white strips. The white area denotes similar genes in which three of four are the same. The unique genes are marked as color bands: 1) T3/HDF, orange; 2) T3/CMHDF, blue; 3) T5/MEF, red; 4) T3/CMMEF, green. B. The top 10 GeneGo canonical pathway maps.
Tgf Beta Signalling, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf-beta signalling/product/BioCarta
Average 90 stars, based on 1 article reviews
tgf-beta signalling - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Royalty Pharma targeted therapies against epac/rap/jnk pathway
Comparison of gene expression and <t>GeneGo</t> <t>canonical</t> <t>pathway</t> <t>maps</t> among T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells . A. Parameters for comparison are set at threshold of 3 with p-value of 0.05. The common genes are indicated by blue/white strips. The white area denotes similar genes in which three of four are the same. The unique genes are marked as color bands: 1) T3/HDF, orange; 2) T3/CMHDF, blue; 3) T5/MEF, red; 4) T3/CMMEF, green. B. The top 10 GeneGo canonical pathway maps.
Targeted Therapies Against Epac/Rap/Jnk Pathway, supplied by Royalty Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/targeted therapies against epac/rap/jnk pathway/product/Royalty Pharma
Average 90 stars, based on 1 article reviews
targeted therapies against epac/rap/jnk pathway - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics three-dimensional biomimetic scaffolds
Comparison of gene expression and <t>GeneGo</t> <t>canonical</t> <t>pathway</t> <t>maps</t> among T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells . A. Parameters for comparison are set at threshold of 3 with p-value of 0.05. The common genes are indicated by blue/white strips. The white area denotes similar genes in which three of four are the same. The unique genes are marked as color bands: 1) T3/HDF, orange; 2) T3/CMHDF, blue; 3) T5/MEF, red; 4) T3/CMMEF, green. B. The top 10 GeneGo canonical pathway maps.
Three Dimensional Biomimetic Scaffolds, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/three-dimensional biomimetic scaffolds/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
three-dimensional biomimetic scaffolds - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

N/A
Boster Bio Anti-FRS2 Monoclonal Antibody catalog # M02798. Tested in WB, IP, Flow Cytometry applications. This antibody reacts with Human.
  Buy from Supplier

Image Search Results


ESK inhibits MAPK pathway activation in the SDH of BCP rats. ( A–D ) Representative WB images and quantification of phosphorylated JNK ( B ), p38 ( C ), and ERK ( D ) levels. Data are mean ± SEM of biological replicates n = 3. *** P < 0.001 versus sham plus vehicle group, # P < 0.05, ## P < 0.01, ### P < 0.001 versus BCP plus vehicle group, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test. ( E ) Schematic of experimental timeline showing repeated intrathecal administration of ESK, SB203580 (p38 inhibitor), or SP600125 (JNK inhibitor) on POD 13 to 16. ( F ) Co-treatment with ESK enhanced the MAPK inhibitors induced increase in PWT after intrathecal administration. Notably, co-administration of MAPK inhibitors did not further enhance ESK’s analgesic effect, suggesting that its antinociceptive action mainly involves MAPK pathway inhibition. Data are mean ± SEM of biological replicates n = 7–8 rats/group. Two-way ANOVA with repeated measures followed by post hoc Tukey test. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. BCP + DMSO; # P < 0.05, BCP + ESK+SB203580 vs. BCP + SB203580, BCP + ESK+SP600125 vs. BCP + SP600125 at corresponding time points. ( G ) Western blot of IL-1β, IL-6, and TNF-α expression in the SDH. ( H–J ) Quantification of cytokine levels showed further reductions in IL-1β ( H ), IL-6 ( I ), and TNF-α ( J ) with combined ESK and MAPK inhibitor treatment. Data are mean ± SEM of biological replicates n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test.

Journal: Scientific Reports

Article Title: Esketamine attenuates bone cancer pain by suppressing MAPK signaling and glial activation in the spinal dorsal horn of rats

doi: 10.1038/s41598-026-38137-y

Figure Lengend Snippet: ESK inhibits MAPK pathway activation in the SDH of BCP rats. ( A–D ) Representative WB images and quantification of phosphorylated JNK ( B ), p38 ( C ), and ERK ( D ) levels. Data are mean ± SEM of biological replicates n = 3. *** P < 0.001 versus sham plus vehicle group, # P < 0.05, ## P < 0.01, ### P < 0.001 versus BCP plus vehicle group, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test. ( E ) Schematic of experimental timeline showing repeated intrathecal administration of ESK, SB203580 (p38 inhibitor), or SP600125 (JNK inhibitor) on POD 13 to 16. ( F ) Co-treatment with ESK enhanced the MAPK inhibitors induced increase in PWT after intrathecal administration. Notably, co-administration of MAPK inhibitors did not further enhance ESK’s analgesic effect, suggesting that its antinociceptive action mainly involves MAPK pathway inhibition. Data are mean ± SEM of biological replicates n = 7–8 rats/group. Two-way ANOVA with repeated measures followed by post hoc Tukey test. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. BCP + DMSO; # P < 0.05, BCP + ESK+SB203580 vs. BCP + SB203580, BCP + ESK+SP600125 vs. BCP + SP600125 at corresponding time points. ( G ) Western blot of IL-1β, IL-6, and TNF-α expression in the SDH. ( H–J ) Quantification of cytokine levels showed further reductions in IL-1β ( H ), IL-6 ( I ), and TNF-α ( J ) with combined ESK and MAPK inhibitor treatment. Data are mean ± SEM of biological replicates n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. One-way ANOVA with repeated measures followed by post hoc Tukey test.

Article Snippet: To assess MAPK pathway involvement, the JNK inhibitor SP600125 (5 μg/10 μl; Cell Signaling Technology, USA) and the p38 inhibitor SB203580 (10 μg/10 μl; Abcam, UK) were dissolved in DMSO to a final DMSO concentration of 1%.

Techniques: Activation Assay, Inhibition, Western Blot, Expressing

Comparison of gene expression and GeneGo canonical pathway maps among T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells . A. Parameters for comparison are set at threshold of 3 with p-value of 0.05. The common genes are indicated by blue/white strips. The white area denotes similar genes in which three of four are the same. The unique genes are marked as color bands: 1) T3/HDF, orange; 2) T3/CMHDF, blue; 3) T5/MEF, red; 4) T3/CMMEF, green. B. The top 10 GeneGo canonical pathway maps.

Journal: BMC Cell Biology

Article Title: A feeder-free culture using autogeneic conditioned medium for undifferentiated growth of human embryonic stem cells: Comparative expression profiles of mRNAs, microRNAs and proteins among different feeders and conditioned media

doi: 10.1186/1471-2121-11-76

Figure Lengend Snippet: Comparison of gene expression and GeneGo canonical pathway maps among T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells . A. Parameters for comparison are set at threshold of 3 with p-value of 0.05. The common genes are indicated by blue/white strips. The white area denotes similar genes in which three of four are the same. The unique genes are marked as color bands: 1) T3/HDF, orange; 2) T3/CMHDF, blue; 3) T5/MEF, red; 4) T3/CMMEF, green. B. The top 10 GeneGo canonical pathway maps.

Article Snippet: Among these common and/or similar genes, cell adhesion was also involved in three of the top 10 GeneGo canonical pathway maps and two of the top 10 GO process networks.

Techniques: Comparison, Gene Expression